newsfilter
← Latest News
PR Newswire·

Eiger Receives European Approval for Zokinvy® (lonafarnib) for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies

First and only treatment approved in Europe to treat Hutchinson-Gilford progeria syndrome and processing-deficient progeroid laminopathies1 Extended life by an average of 4.3 years in children and young adults with HGPS2 Now approved for use in 30 Eu